RituximabMild tranfusion reaction following off-label use of rituximab: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1707卷 / 1期

关键词：

D O I：

10.1007/s40278-018-48057-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：241 / 241

相关论文

共 50 条

[1] RituximabPneumonia and hypogammaglobulinaemia following off-label use of rituximab: case report
Reactions Weekly, 2021, 1841 (1) : 213 - 213
[2] BleomycinOedematous reaction following off-label use: case report
Reactions Weekly, 2023, 1980 (1) : 92 - 92
[3] RituximabInfusion reaction following off-label use: case report
Reactions Weekly, 2018, 1726 (1) : 294 - 294
[4] InfliximabInfusion reaction following an off-label use: case report
Reactions Weekly, 2021, 1845 (1) : 210 - 210
[5] AnakinraHypersensitivity reaction following an off-label use of anakinra: case report
Reactions Weekly, 2022, 1898 (1) : 41 - 41
[6] AnakinraInjection site reaction following off-label use: case report
Reactions Weekly, 2019, 1749 (1) : 43 - 43
[7] InfliximabImmediate hypersensitivity reaction following off-label use: case report
Reactions Weekly, 2019, 1760 (1) : 116 - 116
[8] DexamethasoneLeukaemoid reaction and mucormycosis following off-label use: case report
Reactions Weekly, 2023, 1982 (1) : 163 - 163
[9] Dupilumab/OmalizumabAnaphylactic reaction following off-label use: case report
Reactions Weekly, 2024, 2038 (1) : 126 - 126
[10] DexamethasoneHyperglycaemia following off-label use: case report
Reactions Weekly, 2022, 1896 (1) : 173 - 173

← 1 2 3 4 5 →